跳至主要内容
临床试验/IRCT20210419051012N1
IRCT20210419051012N1尚未招募2 期

The effect of Oleoylethanolamide (OEA) supplementation on oxidative stress parameters in multiple sclerosis patients : A randomized clinical trial

Hamedan University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 40 years(—)
性别
All

入选标准

  • MS type of relapsing_remitting
  • MS patients are treating with beta interferon
  • Willingness to cooperate
  • Patients with an age range of 20 to 40 years

排除标准

  • MS patients are treating with Corticosteroids
  • Taking immunosuppressive drugs
  • History of rheumatic and collagen and vascular diseases History of recent infections (during the last 2 to 3 months)
  • Swallowing disorders that are unable to take medication
  • Sensitivity to compounds
  • No regular use of supplements
  • Reluctance to cooperate

研究者

相似试验

The effect of Oleoylethanolamide supplementation on... | 临床试验